SNTI
Senti Biosciences Inc
NASDAQ: SNTI · HEALTHCARE · BIOTECHNOLOGY
$0.92
-5.99% today
Updated 2026-04-30
Market cap
$29.75M
P/E ratio
—
P/S ratio
1,352.38x
EPS (TTM)
$-2.73
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Senti Biosciences Inc (SNTI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-18.38M | $-24.17M | $-34.63M | $-34.90M | $-52.40M | $-41.40M | $-43.44M |
| Capital expenditures | $2.00M | $1.16M | $5.54M | $41.37M | $12.04M | $26000.00 | $196000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $205000.00 | $272000.00 | $2.29M | $16.39M | $9.67M | $1.75M | $5.71M |
| Free cash flow | $-20.37M | $-25.33M | $-40.18M | $-76.27M | $-64.43M | $-41.42M | $-43.64M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | $3894.00 | $5.17M | $404000.00 | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $1.70M | — | — | — |